The Irish Competition Authority clears acquisition of a pharmaceutical retail chain's parent company by its rival subject to commitments (Uniphar / LXV Remedies)

Competition Authority, Irish

Previous article The UK Competition Authority unwinds dough deal to protect grocers and shoppers (Cérélia / Jus-Rol) Next article The Cypriot Competition Authority launches a full investigation into a merger regarding the transfer of an aircraft business to a joint venture (L.G.S. Handling / Swissport)

20 Jan 2023

The Irish Competition Authority clears acquisition of a pharmaceutical retail chain’s parent company by its rival subject to commitments (Uniphar / LXV Remedies)

KEYWORDS

Reference

Irish Competition Authority, Uniphar / LXV Remedies, Press release, 20 January 2023

CCPC requires binding commitments from Uniphar to acquire Sam McCauley Chemists* The Competition and Consumer Protection Commission (CCPC) has cleared, subject to a number of legally binding commitments, the proposed acquisition by Uniphar PLC (Uniphar) of sole control of LXV Remedies (M/22/049). LXV Remedies is the parent company of Sam McCauley Chemists Limited (Sam

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Irish Competition Authority
Irish Competition Authority (Dublin)

Ireland 86 contributions 13980 visits

Quotation

Irish Competition Authority, The Irish Competition Authority clears acquisition of a pharmaceutical retail chain’s parent company by its rival subject to commitments (Uniphar / LXV Remedies), 20 January 2023, e-Competitions January 2023 - II, Art. N° 110682

Visites 37